Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells  by Brightman, Frances A & Fell, David A
Hypothesis
Di¡erential feedback regulation of the MAPK cascade underlies the
quantitative di¡erences in EGF and NGF signalling in PC12 cells
Frances A. Brightman*, David A. Fell
School of Biological and Molecular Sciences, Oxford Brookes University, Oxford OX3 0BP, UK
Received 17 July 2000; accepted 2 September 2000
Edited by Julio Celis
Abstract Although epidermal growth factor (EGF) induces
transient activation of Ras and the mitogen-activated protein
kinase (MAPK) cascade in PC12 cells, whereas nerve growth
factor (NGF) stimulates sustained activation, the basis for these
contrasting responses is not known. We have developed a
computer simulation of EGF-induced MAPK cascade activation,
which provides quantitative evidence that feedback inhibition of
the MAPK cascade is the most important factor in determining
the duration of cascade activation. Hence, we propose that the
observed quantitative differences in EGF and NGF signalling can
be accounted for by differential feedback regulation of the
MAPK cascade. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
The PC12 rat phaeochromocytoma cell line has been used
extensively for studying nerve growth factor (NGF) signal
transduction, but is also responsive to other growth factors,
including epidermal growth factor (EGF); the latter stimu-
lates the proliferation of PC12 cells, whereas NGF stimulates
di¡erentiation [1]. Both EGF and NGF activate a cytosolic
signal transduction pathway comprising the small guanine nu-
cleotide binding protein, Ras, and a mitogen-activated protein
kinase (MAPK) cascade formed by Raf, MAPK or ERK ki-
nase (MEK) and extracellular signal-regulated kinase (ERK)
protein kinases. In PC12 cells however, EGF causes transient
activation of Ras, MEK and ERK, whilst NGF induces sus-
tained activation of these signalling molecules [1]. The basis
for these quantitative di¡erences in MAPK cascade activation
by EGF and NGF has not yet been established, although
di¡erences in down-regulation of the respective cell-surface
receptors have been implicated as the cause [2]. This explan-
ation assumes that growth factor signalling is attenuated by
receptor internalisation, but it has recently been shown that
internalised EGF receptor (EGFR) is as e¡ective as the cell-
surface receptor in activating Ras [3], and hence a mechanism
acting downstream of the EGFR is more likely to be respon-
sible for down-regulation of the signal generated by EGF.
One possible explanation for the contrasting patterns of
MAPK cascade activation generated by EGF and NGF
may therefore be that the intracellular signals induced by
these growth factors are subject to di¡erential feedback regu-
lation. Other possibilities that have been suggested include
di¡erences in binding a⁄nities of the speci¢c receptors for
substrate molecules, or in receptor tyrosine kinase (RTK) ac-
tivities [4], or di¡erential modulation of some factor that neg-
atively regulates ERK, such as Ras GTPase activating protein
(GAP) or an ERK phosphatase [5]. In order to investigate the
factors in£uencing the kinetics of MAPK cascade activation,
we have developed a computer simulation of the EGF signal
transduction pathway in PC12 cells. Our analysis of this path-
way indicates that negative feedback inhibition of the MAPK
cascade is the most important factor in determining whether
cascade activation is transient or sustained, and that di¡er-
ences in feedback regulation are likely to underlie the charac-
teristic patterns of EGF- and NGF-induced Ras, MEK and
ERK activation in PC12 cells.
2. Model description
We have developed a computer simulation of the EGF
signal transduction pathway [6] that has been implemented
using the biochemical kinetics simulation software package,
Gepasi 3.2 [7]. The model is de¢ned in terms of a number
of signalling molecules and reaction steps, for which rate
equations and kinetic constants are speci¢ed. The software
utilises these data to calculate the change in the concentra-
tions of signalling intermediates over time.
The initial steps of the simulated pathway (Fig. 1) consti-
tute a self-contained simulation of EGF-induced EGFR acti-
vation and internalisation. This is based upon a mathematical
model of the EGFR endocytic pathway [8] that has been
modi¢ed to include ligand-induced receptor dimerisation
[9,10]. The ¢rst step is the binding of EGF (L in the reaction
scheme) to the monomeric cell-surface EGFR (Rs), to form a
receptor^ligand complex (RL) [10]. After ligand binding, RL
complexes associate to yield the R2L2 dimer [9,10]. Activation
of the intrinsic protein tyrosine kinase occurs simultaneously
with dimerisation [11]. Only the active R2L2 species is intern-
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alised via a ligand-induced pathway [12], through binding to
cell-surface coated pit adaptor proteins (CPP). Internalisation
of R2L2 yields an intracellular dimeric species (R2i), which
rapidly dissociates to form the monomeric species (Ri). Inac-
tive Rs and RL complexes are internalised through a consti-
tutive mechanism [12], as are R2L2 complexes not associated
with coated pits. Once internalised, the ligand dissociates from
the receptor (Li) and is degraded. Internalised Ri is then re-
cycled to the cell-surface.
Activated receptors (R2L2, R2i and R2-CPP) catalyse the
tyrosine phosphorylation of the adaptor protein, Src homol-
ogy and collagen domain protein (Shc) [13], yielding ShcP,
which then associates with a constitutive complex formed by
the adaptor protein, growth factor receptor binding protein 2
(Grb2), and the guanylnucleotide exchange factor, Son of
sevenless homologue protein (SOS) (GS) [14], to form the
ternary complex, ShcGS. It is assumed that only uncomplexed
ShcP may be dephosphorylated by cellular protein tyrosine
phosphatases (PTPases), as it is not known whether com-
plexed ShcP is a target for phosphatase activity. Formation
of ShcGS recruits SOS to the plasma membrane where Ras is
localised [14]. Interaction of RasGDP with ShcGS forms a
Ras^ShcGS complex, and enables SOS to stimulate the con-
version of inactive RasGDP to active RasGTP [14].
RasGTP may bind to GAP, yielding a Ras^GAP complex
and stimulating the intrinsic GTPase activity of Ras, so that
RasGTP is converted to RasGDP [15]. Alternatively, RasGTP
may bind to Raf to generate the Ras^Raf complex. This re-
cruits Raf to the plasma membrane and facilitates Raf kinase
activation [16]; the latter is associated with growth factor-
induced serine phosphorylation of Raf [17]. Activated Raf*
catalyses the phosphorylation of two MEK serine residues;
both MEKP and MEKPP are catalytically active [18].
MEKP and MEKPP activate ERK by catalysing the phos-
phorylation of a tyrosine and a threonine residue, but only
ERKPP is active [19]. Dephosphorylation of Raf*, MEKP,
MEKPP and ERKPP is catalysed by the same serine/threo-
nine phosphatase, protein phosphatase 2A (PP2A), however,
ERKP/ERKPP is also dephosphorylated by an, as yet, un-
identi¢ed PTPase [20]. Feedback regulation of the pathway
is mediated by the inhibitory serine/threonine phosphorylation
of SOS, catalysed by ERKPP, resulting in dissociation of the
ShcGS complex to yield ShcP and GSP [21]. GS is regenerated
by dephosphorylation, although the speci¢c phosphatases in-
volved in this process are not known.
All enzyme-catalysed reactions follow Michaelis^Menten
kinetics, whereas all other reactions are represented by
mass^action kinetics. Parameter values are available at
http://bms-mudshark.brookes.ac.uk.
To assess the sensitivity of the behaviour of the pathway to
variations in parameter values, we changed the value of a
selected parameter away from its original value (whilst main-
taining all other parameters at their original values) and ob-
served the e¡ect on the activation state of MAPK cascade
components. The initial values of the selected parameters
are given in Table 1. These values were varied over ranges
consistent with either measured or estimated values speci¢ed
in the literature [22^26].
3. Results and discussion
Numerous reports have demonstrated that EGF stimula-
tion of PC12 cells results in a rapid, transient activation of
Ras, MEK and ERK. The level of RasGTP rapidly reaches a
maximum of up to 20% of total Ras within 2 min exposure to
EGF, but declines to less than 10% within 10 min and grad-
ually returns to the basal level within 60 min [27]. Similarly,
MEK and ERK activation are maximal within 2^5 min, but
MEK activation rapidly declines to less than 15% of the peak
value within 30 min [22,28], whilst ERK activation declines to
less than 50% of the maximum level by 30 min, and to less
than 25% within 60 min [22,28^30]. In order to compare the
time-dependent behaviour of the computer simulation of EGF
signal transduction with these experimental observations, the
time courses of Ras, MEK and ERK activation were com-
puted over 60 min continuous exposure to 100 nM EGF. Fig.
2 demonstrates that the simulated time course patterns of Ras,
MEK and ERK activation are compatible with those typical
Fig. 1. Schematic representation of the computer simulation of
EGF signal transduction. The three active species of receptor
(R2L2, R2i and R2-CPP) are modelled as separate entities in the
simulation, but for convenience these are denoted in the reaction
scheme by the generic term, R*. The numbering of reactions is arbi-
trary.
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of EGF-stimulated PC12 cells, indicating that the computer
simulation is an adequate representation of EGF-induced
MAPK cascade activation in this cell type.
The pattern of NGF-stimulated MAPK cascade activation
in PC12 cells di¡ers from that induced by EGF; NGF has
been shown to induce a rapid activation of Ras, MEK and
ERK that may be largely sustained for up to several hours
[22,27^30]. In order to investigate the basis for this di¡erence
in EGF and NGF signalling through the MAPK kinase cas-
cade, we utilised the computer simulation of EGF signal
transduction in a quantitative analysis of the factors a¡ecting
the time course of cascade activation. By individually varying
the values of kinetic parameters governing a number of signal-
ling events, we have been able to determine the speci¢c e¡ect
of each of these events on the pattern of Ras, MEK and ERK
activation. A summary of the results of this analysis is given
in Table 1.
It has been proposed that the transient activation of Ras
and ERK by EGF in PC12 cells may be due to attenuation of
the signal at or near the level of the EGFR [22,28]. Thus,
sustained Ras and ERK activation may possibly be due to
prolonged activation of high a⁄nity NGF tyrosine kinase
receptor (TrkA) compared to EGFR [31]. Studies involving
manipulation of the expression or down-regulation of growth
factor receptors appear to con¢rm the view that the number
of active cell-surface receptors [2], and hence the strength of
the signal generated [32], determines whether Ras and ERK
activation are sustained. Consequently, we investigated the
in£uence of factors a¡ecting the number of activated cell-sur-
face receptors on the duration of Ras, MEK and ERK acti-
vation, these being the total number of receptors and the rate
of receptor internalisation. Increasing the number of receptors
up to 50-fold had no e¡ect on the time course of MAPK
cascade activation (Table 1), despite prolonging Shc phos-
phorylation (data not shown). Decreasing the rate of receptor
internalisation was also without e¡ect. These results are in
agreement with a recent study indicating that EGFR internal-
isation is not likely to be the predominant mechanism for the
rapid attenuation of EGF-induced Ras activation [3].
It has also been suggested that di¡erences in the kinetics of
receptor interaction with intracellular signalling intermediates
might determine the duration of MAPK cascade activation
[4]. Thus, we also examined the in£uence of the a⁄nity of
the receptor for the adaptor protein, Shc, and the rate of
RTK-catalysed phosphorylation of this protein, but found
that these factors also had no e¡ect on the time course of
Ras, MEK or ERK activation (Table 1), even though Shc
phosphorylation was enhanced (data not shown). Hence,
our results suggest that speci¢c di¡erences in the number of
activated receptors at the cell-surface, or in the intensity of the
signals generated by the receptors, do not underlie the quan-
titative di¡erences in EGF and NGF signalling in PC12 cells,
Fig. 2. Simulated time courses of MAPK cascade activation in
PC12 cells over 60 min continuous exposure to EGF. A: Percentage
of total Ras in the GTP-bound form. B: Percentage of maximal
MEK and ERK activation. Simulation parameters as given in
Table 1.
Table 1
Parameter values of selected steps in the EGF signal transduction pathway, and the e¡ect of variations in these parameters on the duration of
MAPK cascade activation over 60 min simulated continuous exposure to EGF
Reaction number Parameter Value Reference Change
in value
Sustained activation
Ras MEK ERK
1 total receptors, [Rs+Ri] 1.5U104 molecules/cell [22] u U U U
2, 3, 5, 6, 8 ke, receptor internalisation 0.7/min [8] s U U U
9 km, Shc phosphorylation 816 molecules/cell [39] s U U U
9 k, Shc phosphorylation 12/min [39] u U U U
27 k, SOS phosphorylation 1.2/min [26]a s k k k
27 V, SOS dephosphorylation 75 molecules/cell/min [23,25,26]a u k k k
15 k, GAP 720/min [40,41]a s k k k
24, 26 V, ERK PTPase 2.5U105 molecules/cell/min [23,25,26]a s U U k
18 V, PP2A 9.7U104 molecules/cell/min [23,25,26]a s U k k
20, 22 V, PP2A 9.7U105 molecules/cell/min [23,25,26]a s U k k
24, 26 V, PP2A 2.5U105 molecules/cell/min [23,25,26]a s U k k
1 [EGF] 100 nM [29] ^ ^ ^ ^
aThe value assigned to the parameter is consistent with a range of measured or estimated values given in the literature.
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as manipulating the kinetic parameters of the computer sim-
ulation to increase the magnitude of ligand-induced signalling
did not generate sustained MAPK cascade activation.
We next examined the in£uence of factors directly a¡ecting
the persistence of the Shc^Grb2^SOS complex on the duration
of Ras, MEK and ERK activation, since it is likely that EGF
signalling is in fact down-regulated through feedback desensi-
tisation [3], mediated by MEK-dependent serine/threonine
phosphorylation of SOS and resulting in dissociation of the
signalling complex formed by phosphorylated Shc, Grb2 and
SOS [21]. Fig. 3 shows that decreasing the rate of feedback
SOS phosphorylation, or increasing the rate of subsequent
SOS dephosphorylation, and thereby enhancing signalling
via the Shc^Grb2^SOS complex, resulted in sustained activa-
tion of Ras, MEK and ERK (Table 1). Furthermore, Fig. 4
illustrates that a 40-fold increase in rate of SOS dephosphor-
ylation generated a time course of MAPK cascade activation
that is strikingly similar to that observed when PC12 cells are
stimulated with NGF, rather than EGF, with the level of
RasGTP being sustained at around 8% of total Ras [27],
MEK activation maintained at around 50% of the peak value
[22] and ERK activation remaining at almost the maximal
level for at least 60 min [22,28^30]; none of the other param-
eters investigated had a comparable e¡ect on the time course
of MAPK cascade activation. These results are consistent with
experimental data showing that inhibition of the feedback
phosphorylation of SOS prolongs Ras activation [33], and
imply that some di¡erence in feedback regulation of the sig-
nals initiated by EGF and NGF could account for the quan-
Fig. 3. Sensitivity of the duration of MAPK cascade activation to
variations in the values of kinetic parameters governing the feed-
back phosphorylation of SOS. The e¡ect of (A) decreasing k, SOS
phosphorylation, and (B) increasing V, SOS dephosphorylation on
the activation state of the MAPK cascade after 60 min simulated
continuous exposure to EGF. The curves indicate the percentage of
Ras in the GTP-bound form, and the percentage of maximal MEK
and ERK activation.
Fig. 4. Sustained activation of the MAPK cascade resulting from a
40-fold increase in the rate of SOS dephosphorylation, over 60 min
simulated continuous exposure to EGF. Time courses of (A) per-
centage of total Ras in the GTP-bound form, and (B) percentage
of maximal MEK and ERK activation. V, SOS dephosphoryla-
tion = 3U103 molecules/cell/min. Other parameter values as given in
Table 1.
Fig. 5. Sensitivity of the duration of MAPK cascade activation to
decreasing GAP activity. The e¡ect of decreasing k, GAP on the ac-
tivation state of the MAPK cascade after 60 min simulated continu-
ous exposure to EGF. The curves indicate the percentage of Ras in
the GTP-bound form, and the percentage of maximal MEK and
ERK activation.
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titative di¡erences in EGF and NGF signalling in PC12 cells.
Furthermore, our results support the hypothesis that NGF,
but not EGF, enhances phosphatase activity towards phos-
phorylated SOS, resulting in sustained signalling through the
Shc^Grb2^SOS complex. Although ERK is generally impli-
cated in the feedback phosphorylation of SOS, there is evi-
dence that additional kinases may be involved, such as the
downstream target of ERK, p90 Rsk-2 [34]. Moreover, the
kinases responsible for catalysing SOS phosphorylation ap-
pear to vary with the cell-surface receptor, with the e¡ect on
the stability of the signalling complex depending upon the site
of phosphorylation [35]. Hence, it is possible that EGF and
NGF may induce the phosphorylation of SOS by di¡erent
kinases, and thereby at distinct phosphorylation sites, result-
ing in di¡ering e¡ects on complex regulation [34] ; in the case
of NGF, this might generate a substrate that is more readily
dephosphorylated by cellular phosphatases, thus increasing
the rate at which functional Shc^Grb2^SOS is reconstituted.
Di¡erential regulation of the Grb2^SOS complex by EGF and
NGF in PC12 cells has in fact been observed, with EGF
stimulating a small transient increase in Grb2^SOS associa-
tion, and NGF inducing an initial decline in detectable Grb2^
SOS complexes, followed by a phase of sustained Grb2^SOS
association [36].
Another potential mechanism for regulating the duration
and magnitude of MAPK cascade activation would be mod-
ulation of the activity of negative regulators of the cascade [5],
but this was not supported by our analysis of the in£uence of
the activity of GAP and protein phosphatases on the duration
of cascade activation. Reducing the activity of GAP increased
the duration of Ras, MEK and ERK activation (Table 1),
although in order to sustain MEK and ERK activation at a
substantial level it was necessary to virtually eliminate GAP
activity, resulting in Ras activation being maintained at a level
far in excess of that observed experimentally (Fig. 5). As no
di¡erential e¡ect of EGF and NGF on GAP activity in vivo
has been described, it therefore seems improbable that mod-
ulation of GAP activity represents a physiological mechanism
for regulating the duration of MAPK cascade activation. Re-
ducing ERK PTPase activity marginally enhanced ERK acti-
vation, although this consequently ampli¢ed the feedback in-
hibition of Ras, and thereby diminished the activation of both
Ras and MEK (Table 1; Fig. 6A). Consistent with PP2A
being the predominant phosphatase activity acting at all
points in the MAPK cascade [20], reducing PP2A activity
had a more pronounced positive e¡ect on the duration of
both MEK and ERK activation, but again resulted in a re-
duction in Ras activation (Table 1; Fig. 6B). Thus, in con-
junction with con£icting experimental data [30], our analysis
indicates that negative modulation of either ERK PTPase or
PP2A activity by NGF is also unlikely to play a major role in
sustaining MAPK cascade activation.
4. Conclusions
Through a quantitative analysis of a computer simulation
of the EGF signal transduction pathway in PC12 cells, we
have presented evidence that the characteristic di¡erences in
the pattern of EGF- and NGF-induced MAPK cascade acti-
vation observed in PC12 cells are unlikely to simply be due to
di¡erences in the persistence or intensity of cell-surface recep-
tor signalling, or in the modulation of GAP or MAPK cas-
cade phosphatase activity. Instead, we conclude that some
di¡erence in the negative feedback regulation of the cascade
is predominantly responsible for determining whether activa-
tion is transient or sustained. Although other regulatory
mechanisms may be involved, these are likely to play a sec-
ondary role. Our results clearly demonstrate that unless feed-
back inhibition of the signal is counteracted, intensifying the
signal at the cell-surface level is likely to be without e¡ect, and
enhancing ERK activation alone paradoxically reduces Ras
and MEK activation, generating a pattern of activation that
is incompatible with experimental observation. Our analysis
therefore suggests a model that accounts for the sustained
activation of the MAPK cascade in PC12 cells by NGF, but
not EGF. Both EGF and NGF initially activate the Ras/Raf/
MEK/ERK cascade via formation of the Shc^Grb2^SOS sig-
nalling complex. In the case of the EGF, this signal is rapidly
terminated through the negative feedback phosphorylation of
SOS, resulting in dissociation of the Shc^Grb2^SOS complex,
mediated by a kinase downstream of MEK. Similarly, in the
case of NGF there is initial down-regulation of the signal
through Shc^Grb2^SOS, resulting in a transient decline in
the level of MEK and ERK activation by 30 min exposure
to growth factor, which has been observed in certain studies
[22,29]. However, the rapid reconstitution of functional Grb2^
SOS, through enhanced SOS dephosphorylation, facilitates a
second sustained phase of MEK and ERK activation, which
has again been observed [22,29]. Shc-independent pathways
Fig. 6. Sensitivity of the duration of MAPK cascade activation to
variations in the values of kinetic parameters governing ERK
PTPase and PP2A activity. The e¡ect of (A) decreasing V, ERK
PTPase, and (B) decreasing V, PP2A on the activation state of the
MAPK cascade after 60 min simulated continuous exposure to
EGF. The curves indicate the percentage of Ras in the GTP-bound
form, and the percentage of maximal MEK and ERK activation.
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for Ras activation (not represented in the computer simula-
tion), such as via the association of activated TrkA with the
lipid-anchored docking protein, suc1-associated neurotrophic
factor target/¢broblast growth factor receptor substrate 2 [5],
in combination with the adaptors Grb2 and Crk, and guanyl-
nucleotide exchange factors, SOS and C3G [37], may also
contribute to sustained MAPK cascade activation, since these
are presumably not subject to the same negative feedback
regulation as signalling through the Shc^Grb2^SOS complex.
Finally, although it has been acknowledged that initial acti-
vation of the MAPK cascade is mediated by Ras, a parallel
pathway involving activation of the Ras-like GTPase, Rap1,
via Crk and C3G, has been linked with the sustained phase of
ERK activation [38]. Although this Ras-independent pathway
may be su⁄cient to enhance MEK and ERK activation, the
evidence presented here implies that this alone would be asso-
ciated with a decline in the Ras activation level, which is in
contrast to experimental observation. Hence, suppression of
the feedback inhibition of Ras activation, possibly mediated
through enhanced SOS dephosphorylation, is also necessary
to account for all the experimentally observed e¡ects of NGF
stimulation of PC12 cells on Ras/Raf/MEK/ERK cascade ac-
tivation.
Although many growth factor signal transduction mecha-
nisms have been characterised qualitatively, there is still a lack
of quantitative data. Whilst our conclusions are based largely
on a theoretical analysis of a current issue in growth factor
signalling, this work has demonstrated that by taking a more
quantitative approach to studying the regulation of cellular
signalling, it is possible to gain valuable insights into areas
that are still not fully understood, and to determine new di-
rections for future experimental work.
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